If you took two montelukast tablets instead of one, serious toxicity is unlikely. In poison-center records of 17,069 montelukast exposures in children aged 5 to 17, single ingestions as high as 445 mg were rarely linked to any adverse events. Do not take another dose. But montelukast carries a boxed warning, and that changes what you should be watching for.
Here is the part most pages skip: with montelukast, the thing to keep an eye on is not your stomach. It is your mood, your sleep, and your behavior. That is not because one extra tablet causes those changes. It is because this drug carries a warning about them at any dose, and this is a moment when you are already paying attention.
Why doubling up on this one feels different
Montelukast is easy to double. It is a once-daily tablet, usually taken in the evening, often for years at a time. Anything you take that automatically stops being a decision and becomes a reflex, and reflexes do not leave memories. You reach for the bottle, and twenty minutes later you genuinely cannot tell whether that was tonight or last night.
The FDA prescribing information for montelukast addresses this directly. Its guidance for a missed dose reads: "Patients who miss a dose should take the next dose at their regular time and should not take 2 doses at the same time."
That line exists because doubling up is the common mistake, not a rare one. It is the same reflex problem behind taking two blood pressure pills by mistake, and the same reason people cannot remember if they took their inhaler or end up taking extra puffs of a controller inhaler.
Montelukast sits in the same daily routine as allergy tablets for a lot of people, which is part of why the mix-up happens. If you are stacking several of them, how allergy medications behave in hot weather is worth a read separately. And if the doubling happened with your rescue inhaler rather than the tablet, extra puffs of albuterol is a different situation with a more urgent answer.
What 20 mg of montelukast actually does in your body
A doubled adult dose is 20 mg, since the standard adult tablet is a 10 mg film-coated tablet. Three numbers from the label explain why that amount clears quickly.
Montelukast reaches its peak blood level in 3 to 4 hours. Its mean plasma half-life in healthy young adults runs 2.7 to 5.5 hours. And it leaves your body mainly through your gut, not your kidneys: after a radiolabeled dose, 86% of the drug was recovered in stool over five days, and less than 0.2% in urine. It is broken down by the liver enzymes CYP3A4, 2C8 and 2C9.
Put together, a doubled dose peaks in an afternoon and is largely gone within a day. Because clearance runs through bile rather than urine, kidney function is not the usual bottleneck the way it is with some other daily medications.
What the overdose data actually shows
Two large reviews of poison-center calls give a sense of scale.
A 2017 study in Clinical Toxicology reviewed 17,069 montelukast exposures and concluded that "single-dose exposures of montelukast up to 445 mg are rarely associated with any adverse events and are not associated with serious or life-threatening adverse events in children aged 5 to 17 years." In that dataset, 99% of exposures produced no medical effect at all. Abdominal pain was the most common complaint, showing up in under 1% of cases.
A 2019 follow-up by the same group looked at 312 children with recorded body weights, at doses reaching 17.8 mg/kg. Their conclusion: "weight-based doses of montelukast that greatly exceed approved daily doses are rarely associated with adverse events."
For context, an accidental 20 mg is roughly twenty-two times smaller than the largest single ingestion in that first dataset.
Both of those datasets are pediatric. There is no equivalent adult series of this size, so treat the numbers as scale, not as a personal all-clear. What they establish is that this is not a drug where a small multiple of a normal dose is expected to cause serious harm.
The label's own overdose section is brief. It states that "no specific information is available on the treatment of overdosage with montelukast sodium" and recommends "the usual supportive measures." It also notes it is not known whether montelukast is removed by dialysis. No antidote is listed. If you are worried about the amount taken, Poison Control or your pharmacist can give you an answer based on your actual situation.
Why the montelukast boxed warning changes what to watch
Montelukast carries the FDA's most serious label warning. The boxed warning reads: "WARNING: SERIOUS NEUROPSYCHIATRIC EVENTS. Serious neuropsychiatric (NP) events have been reported with the use of montelukast sodium."
The label's warnings section lists eighteen specific events that have been reported:
agitation, aggressive behavior or hostility, anxiousness, depression, disorientation, disturbance in attention, dream abnormalities, dysphemia (stuttering), hallucinations, insomnia, irritability, memory impairment, obsessive-compulsive symptoms, restlessness, somnambulism (sleepwalking), suicidal thoughts and behavior including suicide, tic, and tremor.
The patient counseling section tells you what to do if any of these show up: "Stop taking montelukast sodium tablets and tell your healthcare provider right away if you or your child have any unusual changes in behavior or thinking."
Read that instruction carefully, because it is unusual. For most medications, the advice after an accidental double dose is to watch for physical symptoms and call if you feel unwell. Here, the label tells you to stop the drug and contact your prescriber for a change in thinking or behavior. That is a different kind of monitoring, and it is easy to miss because a mood change does not feel like a drug side effect. It feels like a bad night.
This does not mean a single doubled dose will cause any of it. The warning applies to montelukast use generally, not to accidental double doses specifically. But it does mean that if you are going to pay attention to something for the next day or two, this is the category worth paying attention to.
| Time since the extra tablet | What is happening | What to do |
|---|---|---|
| 0 to 4 hours | Blood level climbing toward its peak | Do not take more. Call Poison Control at 1-800-222-1222 if you want a case-specific read, or your pharmacist |
| 4 to 12 hours | Level falling, roughly one half-life per 3 to 5 hours | Note any headache or stomach discomfort. Neither is common |
| 12 to 24 hours | Most of the extra dose is cleared | Watch sleep and mood, including vivid dreams or restlessness |
| Next scheduled dose | Back to routine | Take it at the usual time unless your prescriber says otherwise |
| Any point, any amount | Unusual change in behavior or thinking | Stop the medication and contact your prescriber right away, per the label |
What to do right now
Do not take a third tablet to balance anything out. There is nothing to correct.
The schedule question is the one worth asking someone about. The label's missed-dose line points patients back to their regular time rather than doubling or skipping, but whether that applies to you is a question for your prescriber or pharmacist. Deciding on your own to skip tomorrow makes the pattern harder to track, and harder to explain if you do end up calling.
If you want an answer built around your actual situation rather than a general one, Poison Control at 1-800-222-1222 is free and staffed around the clock. You do not need to be having an emergency to call. Your pharmacist can do something the hotline cannot, which is pull your full medication list and check the extra dose against everything else you take.
Then write down that it happened, with the date. That sounds fussy for a single tablet. It is not, for this drug specifically: if a sleep or mood change turns up two days from now, the date is the thing that tells you whether the two are even related.
One exception to all of the above. Trouble breathing, swelling of the face or throat, or a rash are not typical of a montelukast double dose, and they need urgent care regardless of what caused them.
If your worry is the opposite problem, that you skipped rather than doubled, what to do after a missed dose covers the general rules. And if the double dose involved a child, confirming whether a dose was already given is usually the more useful place to start.
How Pillo helps
Most double doses are not carelessness. They are the predictable result of a task that is too small to remember and too routine to notice. Pillo's persistent alarm keeps going until you actually mark the dose as taken, which means the log is the answer to "did I already take this?" rather than your memory.
The medication list keeps your record in one place, so if you do need to tell a pharmacist or prescriber what happened and when, you are reading a timestamp instead of reconstructing your evening. For anyone managing an evening tablet alongside other medications, dose spacing alerts flag when two things are scheduled too close together.
For the wider pattern, taking two of the same pill by mistake follows the same logic across other once-daily medications, and taking two antidepressant tablets is an example where the answer runs the other way, with symptoms driving the response.
FAQ
Is 20 mg of montelukast dangerous for an adult?
A doubled 10 mg dose is well below the levels recorded in poison-center data. A 2017 review of 17,069 exposures found that single ingestions up to 445 mg were rarely associated with any adverse events and none that were serious or life-threatening. That review covered children aged 5 to 17, and there is no adult series of comparable size, so it is scale rather than clearance for your situation. Call Poison Control at 1-800-222-1222 or your pharmacist for a personal answer.
Should I skip tomorrow's montelukast because I doubled today?
The FDA label says to take the next dose at the regular time and not to take two doses together. It does not instruct patients to skip after a double dose. Your prescriber may advise differently based on your history, so ask rather than deciding on your own.
How long does montelukast stay in your system?
The label reports a mean plasma half-life of 2.7 to 5.5 hours in healthy young adults, with peak levels reached 3 to 4 hours after a dose. Most of the drug leaves through stool rather than urine, with 86% recovered in five-day fecal collections and under 0.2% in urine.
What symptoms should I actually watch for after taking two?
Physical symptoms are uncommon, and abdominal pain was the most frequent complaint in the poison-center data at under 1% of cases. The label's boxed warning points to a different category: unusual changes in behavior or thinking, including agitation, vivid dreams, sleep disturbance, irritability, or low mood. The label instructs patients to stop the medication and contact their healthcare provider right away if these appear.
My child took an extra montelukast tablet. Is that different?
The poison-center data specifically covers children. A 2019 study of 312 children with recorded weights, at doses reaching 17.8 mg/kg, concluded that doses greatly exceeding approved daily amounts are rarely associated with adverse events. Call Poison Control at 1-800-222-1222 for a case-specific answer, and watch for behavior changes as the label directs.
Can montelukast cause nightmares or vivid dreams?
Dream abnormalities and somnambulism are both named in the boxed-warning symptom list in the FDA label, alongside insomnia. Because montelukast is usually taken in the evening, sleep-related effects are among the ones people notice first. The label's instruction is the same for these as for any other behavior or thinking change: stop the medication and tell your healthcare provider right away.
How much montelukast counts as an overdose?
The label does not define a threshold dose, and it states that no specific information is available on treating an overdose. The largest single ingestion recorded in the 17,069-exposure review was 445 mg, which was still not linked to serious or life-threatening events in that pediatric population. Rather than working from a number, call Poison Control at 1-800-222-1222 with the actual amount and the person's age and weight.
Does montelukast have an antidote?
No. The label states that no specific information is available on treating an overdose and recommends usual supportive measures. It also notes that it is not known whether montelukast is removed by dialysis. This is consistent with a drug where serious toxicity from a single extra dose is not the expected outcome.
This article provides general information about medication management and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before making changes to your medication schedule.
Sources
- FDA DailyMed: Montelukast Sodium prescribing information (label revised 9/2025)
- Arnold DH, et al. "Adverse events are rare after single-dose montelukast exposures in children." Clinical Toxicology, 2017. doi:10.1080/15563650.2017.1337123. Full text: PMC6631372
- Arnold DH, et al. "Adverse events associated with weight-based, high-dose montelukast exposures in children." Clinical Toxicology, 2019. doi:10.1080/15563650.2019.1609686. Full text: PMC7314285
